The nursing management of a patient receiving Prograf as a primary immunosuppressive agent.
This article addresses the issues that are raised when implementing Prograf as a new primary immunosuppressive agent. It focuses on the nurses' role in pre- and post-operative management, with an emphasis on patient assessment/monitoring and education.
Hasselder
A S
AS
Faculty of Healthcare Sciences, Kingston University.
D016903:Drug Monitoring / Q000451:nursing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000451:nursing*; D009730:Nursing Assessment / Q000379:methods; D010347:Patient Care Planning; D010353:Patient Education as Topic / Q000379:methods; D016559:Tacrolimus / Q000627:therapeutic use*; D014181:Transplantation Immunology / Q000187:drug effects
D007166:Immunosuppressive Agents; D016559:Tacrolimus